Philip Mitchell

Philip Mitchell M.B., B.S., M.D., F.R.A.N.Z.C.P., F.R.C.PSYCH. is Professor and Head of the School of Psychiatry, University of New South Wales, Sydney, Australia.

Professor Philip Mitchell was appointed as a professor of the School of Psychiatry at the University of New South Wales in January, 1999 and then as Head of School in May, 2002.

Philip Mitchell's focus of research includes the molecular genetics of bipolar disorder, pharmacological and psychological treatments of bipolar disorder and depression and transcranial magnetic stimulation for depression.

Philip Mitchell is on the editorial boards of Psychiatric Genetics and the World Journal of Biological Psychiatry.

His pharmaceutical firm advisory board appointments have included membership with the Eli Lilly Zyprexa Bipolar Depression Global Advisory Board in 2006.

Philip Mitchell is a consultant psychiatrist with the Black Dog Institute.

Related Sourcewatch articles

 * Drug industry
 * Black Dog Institute

External articles

 * Clare Masters, "Cures killing hundreds", Daily Telegraph July 9, 2007.